¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"compound lipid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® lipid ÇÑ±Û ÁöÁú
¼³¸í   
  »ý¹°Ã¼ ¾È¿¡ Á¸ÀçÇϸ砹°¿¡ ³ìÁö ¾Æ´ÏÇϰí, À¯±â¿ë¸Å¿¡ ³ì´Â À¯±âÈ­ÇÕ¹°À» ÅëÆ²¾î À̸£´Â ¸». Á¼Àº Àǹ̷δ ¹°¿¡ ³ìÁö ¾Ê°í ¾ËÄÚ¿Ã, ÄÝ·Î·ÎÆ÷¸§À̳ª ¿¡Å׸£, º¥Á¨ µîÀÇ ºñ±Ø¼º¿ë¸Å¿¡ ³ì´Â Áö¹æ»êÀÇ ¿¡½ºÅ׸£·Î »ýü¿¡ ÀÌ¿ëµÇ´Â À¯±âÈ­ÇÕ¹°ÀÌ´Ù. ´Ü¼øÁöÁú, º¹ÇÕÁöÁú(ÀÎÁöÁú, ´çÁöÁú, Áö´Ü¹é) ¹× À¯µµÁöÁú(ÁöÁúÀÇ °¡¼öºÐÇØ»ê¹°)·Î ºÐ·ùµÈ´Ù. Æ¯È÷ Áß¼ºÁö¹æÀº Áö¹æ»ê°ú ±Û¸®¼¼¸°°úÀÇ ¿¡½ºÅ׸£·Î ´Ü¹éÁú°ú ´ç°ú ÇÔ²² »ýüÀÇ Áֿ伺ºÐ ¹× ¿¡³ÊÁö¿øÀ¸·Î¼­ Áß¿äÇÏ´Ù. ±¤ÀǷδ ½ºÅ×·ÎÀ̵堵îÀ» Æ÷ÇÔÇØ¼­ È£¸£¸ó, ºñŸ¹Î ·ù·Î¼­ ÀÛ¿ëÇϴ °Í µîÀ¸·Î ´Ù¾çÇÑ »ý¸®ÇÐÀû ±â´ÉÀ» ´ã´çÇϰí ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipid
    ÁöÁú
  • lipid granule
    Áö¹æ°ú¸³
  • lipid infiltration
    ÁöÁúħÀ±
  • lipid layer
    ÁöÁúÃþ
  • lipid pneumonia
    ÁöÁúÆó·Å
  • lipid proteinosis
    ÁöÁú´Ü¹éÁõ
  • lipid solubility
    ÁöÁú¿ëÇØµµ
  • lipid storage disease
    ÁöÁúÃàÀûº´
  • lipid-soluble
    Áö¿ë¼º-
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipid
    ÁöÁú
  • compound
    º¹Àâ, º¹ÇÕ, È­ÇÕ¹°
  • organic compound
    À¯±âÈ­ÇÕ¹°
  • compound nevus
    º¹ÇÕ¸ð¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipid storage disease
    ÁöÁúÃàÀûº´
  • lipid granule
    Áö¹æ°ú¸³
  • lipid hypothesis
    ÁöÁú°¡¼³
  • lipid infiltration
    ÁöÁúħÀ±
  • lipid
    ÁöÁú
  • lipid-soluble
    Áö¿ë¼º-
  • lipid layer
    ÁöÁúÃþ
  • lipid pneumonia
    ÁöÁúÆó·Å
  • lipid proteinosis
    ÁöÁú´Ü¹éÁõ
  • lipid solubility
    ÁöÁú¿ëÇØµµ
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Dorfman-Chanarin syndrome = neutral lipid storage disease
    Áß¼ºÁö¹æÃàÀûÁõ
  • Lipid Research Clinic
    ÁöÁú¿¬±¸Áø·á¼Ò
  • Lipid bilayer
    Áö¹æÀÌÁßÃþ(ò·Û¸ì£ñìöµ)
  • free radical formation,lipid peroxidation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ÁöÁú °ú»êÈ­(ò·òõ Φ߫ûù)
  • granule, lipid
    Áö¹æ°ú¸³
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°.
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°(¡­ûùùêÚª).
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦.
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°.
  • heme compound
    ÇðÈ­ÇÕ¹°
  • heterocyclic compound
    ÇìÅ×·Î°í¸®È­ÇÕ¹°, ÀÌÁ¾¿øÀÚ°í¸®È­ÇÕ¹°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood lipid
    Ç÷¾×ÁöÁú(úìäûò·òõ).
  • fecal lipid
    ºÐº¯Áö¹æ
  • free radical formation,lipid peroxidation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ÁöÁú °ú»êÈ­(ò·òõ Φ߫ûù)
  • granule, lipid
    Áö¹æ°ú¸³
  • lipid
    ÁöÁú(ò·òõ)
  • lipid
    ÁöÁú(ò·òõ).
  • lipid
    ÁöÁú(ò·òõ)
  • lipid A
    ÁöÁú A
  • lipid cell tumor
    ÁöÁú¼¼Æ÷ Á¾¾ç(¡­á¬øà ðþåË)
  • lipid drop
    Áö¹æ¹æ¿ï
  • lipid droplet
    Áö¹æ¹æ¿ï
  • lipid hypothesis
    ÁöÁú°¡¼³
  • lipid infiltration
    ÁöÁúħÀ±(¡­öÕëÈ).
  • lipid keratopathy
    ÁöÁú°¢¸·º´Áõ
  • lipid matabolism
    Áö¹æ´ë»ç(ò·Û¸ÓÛÞó)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lipid drop
    Áö¹æ¹æ¿ï
    [¿¾ ¿ë¾î] Áö¹æ¼ÒÀû
  • Lipid droplet
    Áö¹æ¹æ¿ï
    [¿¾ ¿ë¾î] Áö¹æ¼ÒÀû
  • Compound gland
    º¹ÇÕ»ù
    [¿¾ ¿ë¾î] º¹ÇÕ¼±
  • Compound intercellular junction
    º¹ÇÕ¼¼Æ÷»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] º¹ÇÕ¼¼Æ÷°£°áÇÕ[¿¬Á¢]
  • Compound intercellular junction
    º¹ÇÕ¼¼Æ÷»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] º¹ÇÕ¼¼Æ÷¿¬Á¢
  • Compound joint
    º¹ÇÕ°üÀý
    [¿¾ ¿ë¾î] º¹°üÀý
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbamate compound
    Ä«¹Ù¸ÞÀÌÆ®°è »ìÃæÁ¦
  • chlorinated hydrocarbon compound
    À¯±â¿°¼Ò°è»ìÃæÁ¦
  • organophosphorus compound
    À¯±âÀΰè»ìÃæÁ¦
  • pyrethroid compound
    ÇÇ·¹½º·ÎÀ̵å°è»ìÃæÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compound lipid
    "È­ÇÕÁöÁú(ûùùêò·òõ), (ÔÒ) complex lipid"
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alicyclic compound
    ºñ(Þª)°í¸®Çü(û¡)È­ÇÕ¹°(ûùùêÚª)
  • anticancer compound
    Ç×¾ÏÈ­ÇÕ¹°(ù÷äßûùùêÚª)
  • antithyroid compound
    Ç×°©»ó¼± È­ÇÕ¹°(ù÷Ë£ßÒàÍûùùêÚª)
  • azo compound
    ¾ÆÁ¶È­ÇÕ¹°(ûùùêÚª)
  • carbamino compound
    Ä«¸£¹Ù¸¶À̵å È­ÇÕ¹°(ûùùêÚª)
  • compound
    È­ÇÕ¹°(ûùùêÚª)
  • compound microscope
    º¹ÇÕÇö¹Ì°æ(ÜÜùêúéÚ°Ìð)
  • diazo compound
    µð¾ÆÁ¶ È­ÇÕ¹°(ûùùêÚª)
  • diazonium compound
    µð¾ÆÁ¶´½ È­ÇÕ¹°(ûùùêÚª) (ÔÒ) diazonium salt
  • energy-poor compound
    ºó(Þ¸)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • energy-rich compound
    ºÎ(Ý£)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • enzyme-substrate compound
    È¿¼Ò-±âÁú È­ÇÕ¹° (ý£áÈÐñòõûùùêÚª)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • Kendall's compound
    ÄË´Þ È­ÇÕ¹°(ûùùêÚª)
  • labeled compound
    Ç¥ÁöÈ­ÇÕ¹°(øöò½ûùùêÚª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipid bound proton
    Áö¹æ°áÇվ缺ÀÚ
  • lipid-laden
    Áö¹æÀûÀç
  • compound
    È­ÇÕ¹°, ÄÄÆÄ¿îµå
  • compound scan
    º¹ÇÕ½ºÄµ
  • compound scan motion
    º¹ÇÕ½ºÄµ¿îµ¿
  • compound sector
    º¹ÇÕ ºÎä²Ã
  • contact compound scan
    Á¢Ã˺¹ÇÕ½ºÄµ
  • inorganic compound
    ¹«±âÈ­ÇÕ¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
ALLHAT Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial
ANRL antihypertensive neutral renomedullary lipid
BLM bilayer lipid membrane; bimolecular liquid membrane; bleomycin; buccolinguomasticatory
CLL cholesterol-lowering lipid; chronic lymphatic leukemia; chronic lymphocytic leukemia; cow lung lavag...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
C 48/80 Compound 48/80
CAP Compound Action Potential
CMAP Compound motor action potential
CMAP Compound muscle action potential
CNAP Compound nerve action potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lipid bilayer
    Áö¹æÁú Ãþ
    ¼¼Æ÷¸·Àº ÁöÁú ÀÌÁß ÃþÀ̶ó Çϸç, ÀÌ Áö¹æÁú ÃþÀº ÁÖ·Î ÀÎ ÁöÁú¿¡ ÀÇÇØ ±¸¼ºµÇ¾î ÀÖ´Ù. ÀÎ ÁöÁúÀº Ä£¼ö¼º°ú ¼Ò¼ö¼º ºÎÀ§·Î ±¸¼ºµÇ¾î ¼¼Æ÷¸·ÀÇ ¹°Áú À̵¿¿¡ ¿µÇâÀ» ³¢Ä£´Ù. ¶Ç Áö¹æÁú ÃþÀÇ ÄÝ·¹½ºÅ×·ÑÀº ÀÌ ÃþÀÇ ¾ÈÁ¤È­¸¦ µ½´Â´Ù.
  • lipid metabolism
    ÁöÁú ´ë»ç
    °£¿¡¼­ ÈçÈ÷ ÀϾ¸ç Áö¹æ»êÀÇ º£Å¸-»êÈ­ ¹× ¾Æ¼¼Æ® ¾Æ¼¼Å×ÀÌÆ® Çü¼º, ´ç ÁöÁú »ý¼º, ÄÝ·¹½ºÅ×·Ñ ¹× ÀÎ ÁöÁú Çü¼º, ´ç°ú ´Ü¹éÁú·ÎºÎÅÍ Áö¹æÀÇ Àüȯ µîÀÌ °¡Àå ´ëÇ¥ÀûÀÌ´Ù.
  • lipid proteinosis
    ÁöÁú ´Ü¹éÁõ
  • lipid storage
    Áö¹æ ÀúÀå
    Áö¹æ ¼¼Æ÷°¡ ´ã´çÇÏ´Â ±â´ÉÀ¸·Î ü³»¿¡ Èí¼öµÈ Áö¹æÀº ų·Î¹ÌÅ©·ÐÀÇ ÇüÅ·Πü¼øÈ¯À» ÇÏ°Ô µÇ¸ç, Áö¹æ Á¶Á÷ÀÇ ¸ð¼¼Ç÷°ü¿¡ À̸£¸é ³»ÇÇ ¼¼Æ÷ÀÇ ´çÁöÁú ¸®ÆÄ¾ÆÁ¦ÀÇ ÀÛ¿ëÀ¸·Î À¯¸® Áö¹æ»ê°ú ´Ü´ç·ù·Î ºÐÇØµÇ¾î Áö¹æ ¼¼Æ÷¿¡ ÀÇÇØ ´Ü¼ø È®»êÀ¸·Î ¼·ÃëµÈ´Ù. ÀÌ Áö¹æ»êÀº Áö¹æ ÇÕ¼º È¿¼Ò¿¡ ÀÇÇÏ¿© Áß¼º Áö¹æÀ¸·Î ÇÕ¼ºµÇ¸ç Áö¹æ ºÐÇØ È¿¼Ò¸¦ ¾ïÁ¦ÇÏ¿© Áö¹æÀ» ÃàÀû½ÃŲ´Ù.
  • lipid-filled histocyte
    ÁöÁú·Î ä¿öÁø Á¶Á÷±¸
  • addition compound
    ÷°¡ È­ÇÕ¹°
    µÎ °³ ÀÌ»óÀÇ È­ÇÕ¹°, ȤÀº ¿ø¼ÒÀÇ °áÇÕ¿¡ ÀÇÇØ¼­ »ý±ä È­ÇÕ¹°.
  • adsorption compound
    ÈíÂø È­ÇÕ¹°
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦
  • aromatic compound
    ¹æÇâÁ· È­ÇÕ¹°
  • chain compound
    »ç½½ È­ÇÕ¹°
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • compound anchorage
    º¹ÇÕ °íÁ¤
    µÎ °³ ȤÀº ±× ÀÌ»óÀÇ Ä¡¾Æ·ÎºÎÅÍ ÀúÇ×À» ¹Þ´Â ±³Á¤ °íÁ¤.
  • compound cavity
    º¹ÇÕ ¿Íµ¿
    óġµÈ »óÅ¿¡¼­ Ä¡¾ÆÀÇ 2¸éÀÌ Ä§½ÀµÈ ¿ì½Ä º´¼Ò.
  • compound composite odontoma
    º¹ÇÕ¼º Ä¡¾ÆÁ¾, ÁýÇÕ¼º Ä¡¾ÆÁ¾
  • compound dislocation
    º¹Àâ Å»±¸
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
compound lipids Lipids containing N and P atoms in addition to the usual C, H, and O.
Compare: homolipids.
Synonym: compound lipids.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anisotropic lipid A lipid in the form of doubly refractive droplets.
(05 Mar 2000)
annular lipid The layer(s) of lipid bound to and/or surrounding an integral membrane protein.
(05 Mar 2000)
brain lipid Impure cephalin possessing marked haemostatic action when locally applied.
(05 Mar 2000)
galactose-diphosphoglycosyl carrier lipid synthetase <enzyme> Catalyses synthesis of gcl-pp-gal from udp gal and p-gcl; also catalyses exchange between the uridylyl moiety of udpgal and ump
Registry number: EC 2.4.1.-
(26 Jun 1999)
pneumonia, lipid Pneumonia due to aspiration or inhalation of various oily or fatty substances.
(12 Dec 1998)
neutral lipid storage disease <syndrome> Congenital ichthyosis, leukocyte vacuoles, and variable involvement of other organ systems.
Synonym: neutral lipid storage disease.
(05 Mar 2000)
disease, lipid storage A series of disorders due to inborn errors in lipid metabolism resulting in the abnormal accumulation of lipids in the wrong places (Examples include Gaucher, Fabry and Niemann-Pick diseases and metachromatic leukodystrophy).
(12 Dec 1998)
inositol lipid A membrane-anchored phospholipid that transduces hormonal signals by stimulating the release of any of several chemical messengers.
(09 Oct 1997)
isotropic lipid A lipid occurring in the form of singly refractive droplets.
(05 Mar 2000)
lipid <chemical> Any of a heterogeneous group of flats and fatlike substances characterised by being water insoluble and being extractable by nonpolar (or fat) solvents such as alcohol, ether, chloroform, benzene, etc. All contain as a major constituent aliphatic hydrocarbons. The lipids, which are easily stored in the body, serve as a source of fuel, are an important constituent of cell structure and serve other biological functions. Lipids may be considered to include fatty acids, neutral fats, waxes and steroids. Compound lipids comprise the glycolipids, lipoproteins and phospholipids.
(18 Nov 1997)
lipid A The lipid associated with polysaccharide in the lipopolysaccharide of gram-negative bacterial cell walls.
(18 Nov 1997)
lipid A 4'-phosphatase <enzyme> Involved in lipid a biosynthesis in rhizobium leguminosarum
Registry number: EC 3.1.3.-
Synonym: 2-keto-3-deoxyoctulosonate-activated 4'-phosphatase, kdo-activated lipid a 4'-phosphatase
(26 Jun 1999)
lipid A disaccharide synthase <enzyme> Udp-diacyl-n-acetylglucosamine plus 2,3-diacyl-n-acetylglucosamine-1-phosphate yields 2',3'-diacyl-glcn-(beta 1-6)-2,3-diacyl-glcn-1-p plus udp
Registry number: EC 2.4.1.182
Synonym: 2,3-diacyl-n-acetylglucosamine diacyl-n-acetylglucosaminyltransferse, lipid a synthase
(26 Jun 1999)
lipid bilayer <biochemistry> A lamellar organisation of phospholipids that are packed as a bilayer with hydrophobic acyl tails inwardly directed and polar head groups on the outside surfaces.
It is this bilayer that forms the basis of membranes in cells, though in most cellular membranes a very substantial proportion of the area may be occupied by integral proteins. The triple layered appearance of membranes seen in electron microscopy is thought to arise because the osmium tetroxide binds to the polar regions leaving a central, unstained, hydrophobic region.
(31 Dec 1997)
lipid bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lipid
    ÁöÁú
  • compound
    À» ÇÕ¼ºÇÏ´Ù
  • compound
    ÇÕ¼ºÀÇ;È¥¼ºÀÇ;º¹ÇÕÀÇ;º¹ÀâÇÑ;º¹½ÄÀÇ;È­ÇÕÇÑ;ÁýÇÕÀÇ;(¹®ÀåÀÌ)Áß¹®ÀÇ;(³¹¸»ÀÌ)º¹ÇÕÀÇ;(ÀúÅÃ.°øÀåÀÇ)¿ï¾È;±¸³»;È¥ÇÕ¹°;ÇÕ¼º¹°;È­ÇÕ¹°;º¹ÇÕ¾î;ÇÕ¼º¾î;(¿ä¼Ò.¼ººÐµîÀ»)È¥ÇÕÇÏ´Ù;ÇÕ¼ºÇÏ´Ù;(¾à µîÀ»)Á¶Á¦ÇÏ´Ù;¼¯¾î¼­ ¸¸µé´Ù;(ÀÏÀ»)È­ÇØ½ÃŰ´Ù;À̾߱â·Î ÇØ°áÁþ´Ù;»çÈ­ÇÏ°Ô ÇÏ´Ù;(°è
  • compound E
    º¹ÇÕ E¹°Áú
  • compound engine
    º¹½Ä ±â°ü;2´Ü ÆØÃ¢±â°ü
  • compound eye
    º¹¾È;°ã´«
  • compound flower
    µÎ»óÈ­;°ã²É(±¹È­°ú ½Ä¹°µîÀÇ)
  • compound fraction
    COMPLEX FRACTION
  • compound fracture
    °³¹æ °ñÀý
  • compound fruit
    °ã¿­¸Å;º¹°ú 
  • compound householder
    Áö¹æ¼¼´Â ÁÖÀÎÀÌ ¹°±â·Î ÇÏ°í ¼¼µç »ç¶÷
  • compound interest
    º¹¸®
  • compound interval
    º¹ÇÕÀ½Áú
  • compound leaf
    °ãÀÙ;º¹¿±
  • compound microscope
    º¹ÇÕÇö¹Ì°æ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á